For many years, it was believed that when an individual develops liver scarring, it can not be reversed. Today, we know that ...

Liver fibrosis represents a serious worldwide health issue with a prevalence of around 5% in general populations.1 The most ...

Liver fibrosis, a common pathological outcome of chronic liver injury, is a key precursor to cirrhosis and hepatocellular carcinoma. Despite its clinical importance, no effective antifibrotic ...

Autophagy is indispensable for maintaining hepatocyte integrity, metabolic homeostasis, and survival. While several autophagy-related proteins have been studied in hepatic physiology, the specific ...

The study investigates the role of autophagy in hepatic progenitor cells (HPCs) and its potential to modulate exosomal microRNAs (miRNAs) to inhibit liver fibrosis in the context of schistosomiasis, a ...

In addition to generic mechanisms of fibrogenesis that are common to all experimental and human liver disease, there has been progress in elucidating disease-specific mechanisms, in particular in ...

A study reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic ...

A mushroom-based supplement called AHCC may prevent the onset of liver fibrosis by targeting key cells before they trigger scarring and damage. With no current cure for cirrhosis, this discovery could ...

Hepatic steatosis, often triggered by non-alcoholic fatty liver disease (NAFLD), is a leading cause of liver dysfunction globally, affecting approximately 30% of the population. The progression from ...